Cargando…
Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology
Different methods for producing bulk quantities of concentrated and purified SARS-CoV-2 for the use as antigens and for the research into COVID-19 biology were tested.
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596366/ https://www.ncbi.nlm.nih.gov/pubmed/34787781 http://dx.doi.org/10.1007/s10517-021-05329-7 |
_version_ | 1784600347495366656 |
---|---|
author | Chepurnov, A. A. Kazachinskaya, E. I. Kazachkova, E. A. Sharshov, K. A. Kononova, Yu. V. Shelemba, A. A. Alekseev, A. Yu. Gulyeva, M. A. Voevoda, M. I. Shestopalov, A. M. |
author_facet | Chepurnov, A. A. Kazachinskaya, E. I. Kazachkova, E. A. Sharshov, K. A. Kononova, Yu. V. Shelemba, A. A. Alekseev, A. Yu. Gulyeva, M. A. Voevoda, M. I. Shestopalov, A. M. |
author_sort | Chepurnov, A. A. |
collection | PubMed |
description | Different methods for producing bulk quantities of concentrated and purified SARS-CoV-2 for the use as antigens and for the research into COVID-19 biology were tested. |
format | Online Article Text |
id | pubmed-8596366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-85963662021-11-17 Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology Chepurnov, A. A. Kazachinskaya, E. I. Kazachkova, E. A. Sharshov, K. A. Kononova, Yu. V. Shelemba, A. A. Alekseev, A. Yu. Gulyeva, M. A. Voevoda, M. I. Shestopalov, A. M. Bull Exp Biol Med Virology Different methods for producing bulk quantities of concentrated and purified SARS-CoV-2 for the use as antigens and for the research into COVID-19 biology were tested. Springer US 2021-11-17 2021 /pmc/articles/PMC8596366/ /pubmed/34787781 http://dx.doi.org/10.1007/s10517-021-05329-7 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Virology Chepurnov, A. A. Kazachinskaya, E. I. Kazachkova, E. A. Sharshov, K. A. Kononova, Yu. V. Shelemba, A. A. Alekseev, A. Yu. Gulyeva, M. A. Voevoda, M. I. Shestopalov, A. M. Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology |
title | Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology |
title_full | Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology |
title_fullStr | Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology |
title_full_unstemmed | Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology |
title_short | Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology |
title_sort | development of a purified viral preparation for studies of covid-19 (sars-cov-2) biology |
topic | Virology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596366/ https://www.ncbi.nlm.nih.gov/pubmed/34787781 http://dx.doi.org/10.1007/s10517-021-05329-7 |
work_keys_str_mv | AT chepurnovaa developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology AT kazachinskayaei developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology AT kazachkovaea developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology AT sharshovka developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology AT kononovayuv developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology AT shelembaaa developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology AT alekseevayu developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology AT gulyevama developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology AT voevodami developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology AT shestopalovam developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology |